Medicare AdvantageJune 20, 2024
Anthem expands specialty pharmacy precertification list
Effective for dates of service on and after October 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines (including definitions and specific contract provisions/exclusions), take precedence over these precertification rules. They must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
HCPCS codes | Medicare Part B drugs |
J3490, J3590 | Amtagvi (lifleucel) |
J3490, J3590 | iDoseTR (travoprost implant) |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-058746-24-CPN58434
PUBLICATIONS: July 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone